Fundraising FoxBios Partners — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Azitraazitrainc.comNYSE: AZTRSep 2020 · $17M
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)
Board seatStella RobertsonTravis Whitfill· per SEC Form D
Co-investorsConnecticut InnovationsKdT VenturesLeaps by Bayer
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.